Lava Therapeutics
Creates and develops next generation γδ T cell engaging bispecific antibodies for the treatment of cancer. Learn more
Launch date
Employees
Market cap
CAD60.4m
Enterprise valuation
(CAD50m) (Public information from Sep 2024)
Share price
$1.68 LVTX
Company register number 65335740
Utrecht Utrecht (HQ), Amsterdam North Holland (founding location)
Authorizing premium user...